Solar stocks ticked higher as yields fell. The Inv
Post# of 26943
![](/assets/46931549/no_avatar_available_thumb.jpg)
climbed more than 8.1%, with constituents SunRun
and Enphase
gaining 20% and 12%, respectively. Shares of Moderna
climbed 9.3% after trial data showed its experimental cancer vaccine reduced the risk of death or reoccurrence when used alongside Merck’s Keytruda.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)